by admin | Apr 19, 2024 | Article
Please visit https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/statement-september-10-2021-additional-dose-covid-19-vaccine-immunocompromised-following-1-2-dose-series.html for details.
by admin | Apr 19, 2024 | Article
If you’re moderately to severely immunocompromised due to disease or treatment, you may have a lower immune response to COVID-19 vaccination. NACI recommends you get an additional mRNA vaccine dose following your 1- or 2-dose vaccine series. The additional dose should...
by admin | Apr 19, 2024 | Article
Dr. Christine A. Peschken, University of Manitoba, Winnipeg, Manitoba Chair, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS) This research network includes over 30 researchers and personnel involved in the research or its activities at...
by admin | Apr 19, 2024 | Article
Ontario individuals who are immunocompromised can get a fourth dose (booster) three months (84 days) after completion of the three-dose primary series. Please visit https://covid-19.ontario.ca/getting-covid-19-vaccine for more information.
by admin | Apr 19, 2024 | Article
Please visit https://www.canada.ca/en/public-services-procurement/news/2022/02/government-of-canada-signs-new-covid-19-antibody-therapy-agreement.html for details.
by admin | Apr 19, 2024 | Article
Please visit https://rheum.ca/wp-content/uploads/2022/03/FINAL-Updated-PS-on-COVID-19-Vacc-March-25_2022_for-publication.pdf for details.
